Suppr超能文献

用于治疗哮喘的咖啡因。

Caffeine for asthma.

作者信息

Welsh Emma J, Bara Anna, Barley Elizabeth, Cates Christopher J

机构信息

Community Health Sciences, St George's, University of London, Cranmer Terrace, London, UK, SW17 0RE.

出版信息

Cochrane Database Syst Rev. 2010 Jan 20;2010(1):CD001112. doi: 10.1002/14651858.CD001112.pub2.

Abstract

BACKGROUND

Caffeine has a variety of pharmacological effects; it is a weak bronchodilator and it also reduces respiratory muscle fatigue. It is chemically related to the drug theophylline which is used to treat asthma. It has been suggested that caffeine may reduce asthma symptoms and interest has been expressed in its potential role as an asthma treatment. A number of studies have explored the effects of caffeine in asthma, this is the first review to systematically examine and summarise the evidence.

OBJECTIVES

To assess the effects of caffeine on lung function and identify whether there is a need to control for caffeine consumption prior to either lung function or exhaled nitric oxide testing.

SEARCH STRATEGY

We searched the Cochrane Airways Group trials register and the reference lists of articles (August 2009). We also contacted study authors.

SELECTION CRITERIA

Randomised clinical trials of oral caffeine compared to placebo or coffee compared to decaffeinated coffee in adults with asthma.

DATA COLLECTION AND ANALYSIS

Trial selection, quality assessment and data extraction were done independently by two reviewers.

MAIN RESULTS

Seven trials involving a total of 75 people with mild to moderate asthma were included. The studies were all of cross-over design .Six trials involving 55 people showed that in comparison with placebo, caffeine, even at a 'low dose' (< 5mg/kg body weight), appears to improve lung function for up to two hours after consumption. Forced expiratory volume in one minute showed a small improvement up to two hours after caffeine ingestion (SMD 0.72; 95% CI 0.25 to 1.20), which translates into a 5% mean difference in FEV1. However in two studies the mean differences in FEV1 were 12% and 18% after caffeine. Mid-expiratory flow rates also showed a small improvement with caffeine and this was sustained up to four hours.One trial involving 20 people examined the effect of drinking coffee versus a decaffeinated variety on the exhaled nitric oxide levels in patients with asthma and concluded that there was no significant effect on this outcome.

AUTHORS' CONCLUSIONS: Caffeine appears to improve airways function modestly, for up to four hours, in people with asthma . People may need to avoid caffeine for at least four hours prior to lung function testing, as caffeine ingestion could cause misinterpretation of the results. Drinking caffeinated coffee before taking exhaled nitric oxide measurements does not appear to affect the results of the test, but more studies are needed to confirm this.

摘要

背景

咖啡因具有多种药理作用;它是一种弱支气管扩张剂,还能减轻呼吸肌疲劳。其化学结构与用于治疗哮喘的药物茶碱相关。有人提出咖啡因可能减轻哮喘症状,并且人们对其作为一种哮喘治疗方法的潜在作用表示出兴趣。许多研究探讨了咖啡因在哮喘中的作用,这是首次对相关证据进行系统审查和总结的综述。

目的

评估咖啡因对肺功能的影响,并确定在进行肺功能或呼出一氧化氮测试之前是否需要控制咖啡因的摄入量。

检索策略

我们检索了Cochrane Airways Group试验注册库以及文章的参考文献列表(2009年8月)。我们还联系了研究作者。

入选标准

针对成年哮喘患者,比较口服咖啡因与安慰剂或普通咖啡与脱咖啡因咖啡的随机临床试验。

数据收集与分析

两名审查员独立进行试验选择、质量评估和数据提取。

主要结果

纳入了7项试验,共75名轻度至中度哮喘患者。这些研究均为交叉设计。6项涉及55人的试验表明,与安慰剂相比,即使是“低剂量”(<5mg/kg体重)的咖啡因,在摄入后长达两小时内似乎都能改善肺功能。摄入咖啡因后一小时的用力呼气量在长达两小时内有小幅改善(标准化均数差0.72;95%可信区间0.25至1.20),这相当于第一秒用力呼气量平均差异为5%。然而,在两项研究中,摄入咖啡因后第一秒用力呼气量的平均差异分别为12%和18%。呼气中期流速在摄入咖啡因后也有小幅改善,且持续长达四小时。一项涉及20人的试验研究了饮用普通咖啡与脱咖啡因咖啡对哮喘患者呼出一氧化氮水平的影响,得出对该结果无显著影响的结论。

作者结论

咖啡因似乎能使哮喘患者的气道功能适度改善,持续长达四小时。在进行肺功能测试前,人们可能需要至少四小时避免摄入咖啡因,因为摄入咖啡因可能会导致结果解读出现偏差。在进行呼出一氧化氮测量前饮用含咖啡因的咖啡似乎不会影响测试结果,但需要更多研究来证实这一点。

相似文献

1
Caffeine for asthma.
Cochrane Database Syst Rev. 2010 Jan 20;2010(1):CD001112. doi: 10.1002/14651858.CD001112.pub2.
2
Caffeine for asthma.
Cochrane Database Syst Rev. 2001(4):CD001112. doi: 10.1002/14651858.CD001112.
3
Caffeine for asthma.
Cochrane Database Syst Rev. 2000(2):CD001112. doi: 10.1002/14651858.CD001112.
4
Inhaled magnesium sulfate in the treatment of acute asthma.
Cochrane Database Syst Rev. 2017 Nov 28;11(11):CD003898. doi: 10.1002/14651858.CD003898.pub6.
5
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
6
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
7
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
8
Inhaled mannitol for cystic fibrosis.
Cochrane Database Syst Rev. 2018 Feb 9;2(2):CD008649. doi: 10.1002/14651858.CD008649.pub3.
9
Anti-IL5 therapies for asthma.
Cochrane Database Syst Rev. 2017 Sep 21;9(9):CD010834. doi: 10.1002/14651858.CD010834.pub3.
10
Exercise versus airway clearance techniques for people with cystic fibrosis.
Cochrane Database Syst Rev. 2022 Jun 22;6(6):CD013285. doi: 10.1002/14651858.CD013285.pub2.

引用本文的文献

1
Coffee's Impact on Health and Well-Being.
Nutrients. 2025 Aug 5;17(15):2558. doi: 10.3390/nu17152558.
2
Caffeine Consumption Patterns, Health Impacts, and Media Influence: A Narrative Review.
Cureus. 2025 Jun 17;17(6):e86215. doi: 10.7759/cureus.86215. eCollection 2025 Jun.
4
New spirometry recommendations from the Brazilian Thoracic Association - 2024 update.
J Bras Pneumol. 2025 Jan 20;50(6):e20240169. doi: 10.36416/1806-3756/e20240169. eCollection 2025.
5
Caffeine in the Perioperative Setting.
Anesthesiology. 2025 Mar 1;142(3):558-566. doi: 10.1097/ALN.0000000000005259. Epub 2025 Jan 14.
6
Caffeine and Vision: Effects on the Eye.
Turk J Ophthalmol. 2024 Oct 25;54(5):291-300. doi: 10.4274/tjo.galenos.2024.43895.
8
Potential Application of Plant-Derived Compounds in Multiple Sclerosis Management.
Nutrients. 2024 Sep 5;16(17):2996. doi: 10.3390/nu16172996.
9
Untargeted metabolomic analysis reveals different metabolites associated with response to mepolizumab and omalizumab in asthma.
ERJ Open Res. 2024 Aug 5;10(4). doi: 10.1183/23120541.00931-2023. eCollection 2024 Jul.
10
L. alleviates OVA-induced allergic asthma through NF-κB and MMP-9 pathways.
Anim Cells Syst (Seoul). 2024 Aug 1;28(1):381-391. doi: 10.1080/19768354.2024.2383254. eCollection 2024.

本文引用的文献

1
The effect of caffeinated coffee on airway response to methacholine and exhaled nitric oxide.
Respir Med. 2011 Nov;105(11):1606-10. doi: 10.1016/j.rmed.2011.06.006. Epub 2011 Jul 2.
2
Effect of caffeine ingestion on exhaled nitric oxide measurements in patients with asthma.
Am J Respir Crit Care Med. 2004 May 1;169(9):1019-21. doi: 10.1164/rccm.200310-1473OC. Epub 2004 Mar 4.
3
Caffeine decreases exhaled nitric oxide.
Thorax. 2002 Apr;57(4):361-3. doi: 10.1136/thorax.57.4.361.
4
Decrease of histamine induced bronchoconstriction by caffeine in mild asthma.
Thorax. 1993 Aug;48(8):824-6. doi: 10.1136/thx.48.8.824.
6
The bronchodilator effects and pharmacokinetics of caffeine in asthma.
N Engl J Med. 1984 Mar 22;310(12):743-6. doi: 10.1056/NEJM198403223101202.
7
The health consequences of caffeine.
Ann Intern Med. 1983 May;98(5 Pt 1):641-53. doi: 10.7326/0003-4819-98-5-641.
9
Effect of dietary caffeine on airway reactivity in asthma.
Respiration. 1986;50(4):258-64. doi: 10.1159/000194936.
10
The bronchodilator effect of caffeine in adult asthmatics.
Am Rev Respir Dis. 1987 Jan;135(1):173-5. doi: 10.1164/arrd.1987.135.1.173.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验